Investor FAQs

3200 Walnut Street
Boulder, CO 80301 USA
Phone: 303.381.6600
Fax: 303.386.1390

Array BioPharma’s common stock is traded on the Nasdaq Global Market under the symbol ARRY.

Array currently does not pay a dividend on its common stock.

Array currently does not offer a direct stock purchase or dividend reinvestment program.

First Quarter: September 30
Second Quarter: December 31
Third Quarter: March 31
Fourth Quarter: June 30

Array went public on November 17, 2000 at a price to the public of $7.50 per share.

Array was incorporated in February 1998 in Delaware.

As of February 2017, Array employed about 190 people.

American Stock Transfer and Trust Company (AST) acts as transfer agent for Array BioPharma. In this capacity, AST maintains stockholder records for the company and performs all stock registrations, transfers and disbursements. AST also handles all stockholder account requests, including change of address, replacement of lost stock certificates, dividend checks and duplicate 1099s.

American Stock Transfer and Trust Company (AST)
6201 15th Avenue
Brooklyn, NY 11219
Phone (212) 936-5100
Toll Free (800) 937-5449
Fax (718) 765-8718
www.amstock.com


  • Cantor Fitzgerald, Mara Goldstein

  • Chris Shibutani, Cowen & Co.

  • Jefferies & Company, Eun Yang, Ph.D.

  • JP Morgan, Anupam Rama

  • Leerink Swann & Company, Michael Schmidt, Ph.D.

  • PiperJaffray, Edward A. Tenthoff

  • Stifel Nicolaus, Stephen Willey

  • SunTrust Robinson Humphrey, Peter Lawson

  • Wells Fargo, Matthew Andrews


Array’s Board consists of nine members. View the biographies of Array’s Board of Directors and Management Team.

Shares can be purchased through the broker of your choice.